{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:38:54Z","timestamp":1778870334899,"version":"3.51.4"},"reference-count":25,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6,22]]},"abstract":"<jats:p>Recently, reports of severe thromboses, thrombocytopenia, and hemorrhage in persons vaccinated with the chimpanzee adenovirus-vectored vaccine (ChAdOx1 nCoV-19, AZD1222, Vaxzevria; Oxford\/AstraZeneca) against severe acute respiratory syndrome coronavirus 2 have emerged. We describe an otherwise healthy 30-year-old woman who developed thrombocytopenia, ecchymosis, portal vein thrombosis, and cerebral venous sinus thrombosis the second week after she received the ChAdOx1 nCoV-19 vaccine. Extensive diagnostic workup for thrombosis predispositions showed heterozygosity for the prothrombin mutation, but no evidence of myeloproliferative neoplasia or infectious or autoimmune diseases. Her only temporary risk factor was long-term use of oral contraceptive pills (OCPs). Although both the prothrombin mutation and use of OCPs predispose to portal and cerebral vein thrombosis, the occurrence of multiple thromboses within a short time and the associated pattern of thrombocytopenia and consumption coagulopathy are highly unusual. A maximum 4T heparin-induced thrombocytopenia (HIT) score and a positive immunoassay for anti-platelet factor 4\/heparin antibodies identified autoimmune HIT as a potential pathogenic mechanism. Although causality has not been established, our case emphasizes the importance of clinical awareness. Further studies of this potentially new clinical entity have suggested that it should be regarded as a vaccine-induced immune thrombotic thrombocytopenia.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004904","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T15:41:30Z","timestamp":1623944490000},"page":"2569-2574","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":38,"title":["A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-2505","authenticated-orcid":false,"given":"Anne Louise","family":"T\u00f8lb\u00f8ll S\u00f8rensen","sequence":"first","affiliation":[{"name":"Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magalie","family":"Rolland","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Infectious Diseases and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-2645","authenticated-orcid":false,"given":"Jacob","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University Hospital of Copenhagen, North Zealand, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5552-0095","authenticated-orcid":false,"given":"Zitta Barrella","family":"Harboe","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Infectious Diseases and"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper","family":"Roed","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Infectious Diseases and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-4431","authenticated-orcid":false,"given":"Tomas \u00d8.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Infectious Diseases and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Kolte","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Infectious Diseases and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-1658","authenticated-orcid":false,"given":"Daniel","family":"El Fassi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Hillings\u00f8","sequence":"additional","affiliation":[{"name":"Department of Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-5710","authenticated-orcid":false,"given":"Aneta","family":"Radziwon-Balicka","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Sebastian","family":"Soyka","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Copenhagen, North Zealand, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Neurology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Kirkby","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens P.","family":"Goetze","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5716-5899","authenticated-orcid":false,"given":"Mikkel","family":"Gybel-Brask","sequence":"additional","affiliation":[{"name":"Section of Transfusion Medicine, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Birgitte","family":"Lein\u00f8e","sequence":"additional","affiliation":[{"name":"Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry and"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kampmann","sequence":"additional","affiliation":[{"name":"Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Stensballe","sequence":"additional","affiliation":[{"name":"Section of Transfusion Medicine, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;"},{"name":"Department of Anaesthesiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"issue":"10269","key":"2021061715412667200_B1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"key":"2021061715412667200_B2","author":"European Medicines Agency"},{"issue":"4","key":"2021061715412667200_B3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost."},{"issue":"11","key":"2021061715412667200_B4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2021061715412667200_B5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0609.2005.00621.x","article-title":"Incidence and clinical significance of anti-PF4\/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia","volume":"76","author":"Juhl","year":"2006","journal-title":"Eur J Haematol."},{"issue":"5","key":"2021061715412667200_B6","doi-asserted-by":"crossref","first-page":"E229","DOI":"10.1503\/cmaj.121636","article-title":"Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type","volume":"185","author":"Sode","year":"2013","journal-title":"CMAJ."},{"issue":"12","key":"2021061715412667200_B7","first-page":"1271","article-title":"Risk of venous thrombosis in carriers of the prothrombin G2010A variant and factor V Leiden and their interaction with oral contraceptives","volume":"85","author":"Aznar","year":"2000","journal-title":"Haematologica."},{"key":"2021061715412667200_B8","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ."},{"issue":"3","key":"2021061715412667200_B9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med."},{"issue":"4","key":"2021061715412667200_B10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/jcm10040683","article-title":"Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management","volume":"10","author":"Marchetti","year":"2021","journal-title":"J Clin Med."},{"issue":"3","key":"2021061715412667200_B11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood."},{"issue":"3","key":"2021061715412667200_B12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1600-0609.1989.tb00290.x","article-title":"The mechanism of heparin-induced platelet aggregation","volume":"43","author":"Chong","year":"1989","journal-title":"Eur J Haematol."},{"issue":"23","key":"2021061715412667200_B13","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1182\/blood-2018-03-834598","article-title":"Polyreactive IgM initiates complement activation by PF4\/heparin complexes through the classical pathway","volume":"132","author":"Khandelwal","year":"2018","journal-title":"Blood."},{"issue":"7","key":"2021061715412667200_B14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am J Med."},{"issue":"8","key":"2021061715412667200_B15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Expert Rev Hematol."},{"issue":"6","key":"2021061715412667200_B16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537104.2017.1366973","article-title":"Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review","volume":"28","author":"Poudel","year":"2017","journal-title":"Platelets."},{"issue":"3","key":"2021061715412667200_B17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2008.03263.x","article-title":"Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery \u2018spontaneous\u2019 HIT","volume":"7","author":"Pruthi","year":"2009","journal-title":"J Thromb Haemost."},{"issue":"6","key":"2021061715412667200_B18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/09537104.2014.979338","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies","volume":"26","author":"Okata","year":"2015","journal-title":"Platelets."},{"issue":"23","key":"2021061715412667200_B19","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1182\/blood-2014-01-549741","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood."},{"issue":"9","key":"2021061715412667200_B20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/phar.1983","article-title":"Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT)","volume":"37","author":"Karnes","year":"2017","journal-title":"Pharmacotherapy."},{"issue":"22","key":"2021061715412667200_B21","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv."},{"issue":"10","key":"2021061715412667200_B22","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1537-2995.2012.03589.x","article-title":"Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010","volume":"52","year":"2012","journal-title":"Transfusion."},{"issue":"4","key":"2021061715412667200_B23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/cpt.1111","article-title":"A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway","volume":"104","author":"Bartko","year":"2018","journal-title":"Clin Pharmacol Ther."},{"key":"2021061715412667200_B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination [published online ahead of print 9 April 2021]","author":"Schultz","journal-title":"N Engl J Med."},{"key":"2021061715412667200_B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","author":"Greinacher","journal-title":"N Engl J Med."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/12\/2569\/1810319\/advancesadv2021004904.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/12\/2569\/1810319\/advancesadv2021004904.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T15:41:47Z","timestamp":1623944507000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/12\/2569\/476134\/A-case-of-thrombocytopenia-and-multiple-thromboses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,6,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004904","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]}}}